A review of 65 years of human adenovirus seroprevalence

• Main Authors: Franck J. D. Mennechet (Author), Océane Paris (Author), Aline Raissa Ouoba (Author), Sofia Salazar Arenas (Author), Sodiomon B. Sirima (Author), Guy R. Takoudjou Dzomo (Author), Amidou Diarra (Author), Isidore T Traore (Author), Dramane Kania (Author), Karsten Eichholz (Author), Eric A. Weaver (Author), Edouard Tuaillon (Author), Eric J. Kremer (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Human adenovirus (HAdV)-derived vectors have been used in numerous pre-clinical and clinical trials during the last 40 years. Current research in HAdV-based vaccines focuses on improving transgene immunogenicity and safety. Because pre-existing humoral immunity against HAdV types corre...